Non-Standardized Plant Allergenic Extract [EPC]

Non-Standardized Plant Allergenic Extract [EPC] was reported 17668 times

Drugs of the Non-Standardized Plant Allergenic Extract [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL FLATULENCE 155 0.5116
1 BRONCHOLITHIASIS 15 0.4839
2 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 23 0.1285
3 BODY TINEA 57 0.1018
4 FEMALE GENITAL TRACT FISTULA 165 0.0965
5 SERONEGATIVE ARTHRITIS 110 0.0960
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 60 0.0898
7 LYMPH NODE CALCIFICATION 17 0.0876
8 LUPUS VULGARIS 106 0.0841
9 MULTIPLE DRUG THERAPY 56 0.0743
10 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
11 CHOROIDITIS 24 0.0642
12 CHRONIC SINUSITIS 236 0.0628
13 RADICULOPATHY 165 0.0625
14 SEDATION COMPLICATION 157 0.0615
15 RETINITIS 101 0.0584
16 PROCTITIS 161 0.0574
17 MACULAR DEGENERATION 617 0.0516
18 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 90 0.0434
19 CREATININE RENAL CLEARANCE DECREASED 165 0.0412
20 DEEP VEIN THROMBOSIS POSTOPERATIVE 77 0.0384
21 DISLOCATION OF VERTEBRA 86 0.0377
22 INHIBITORY DRUG INTERACTION 53 0.0335
23 SWOLLEN JOINT COUNT INCREASED 103 0.0323
24 INFECTION SUSCEPTIBILITY INCREASED 58 0.0265
25 RHEUMATIC FEVER 102 0.0229
26 FALSE POSITIVE INVESTIGATION RESULT 23 0.0228
27 BONE EROSION 80 0.0226
28 BRONCHIAL WALL THICKENING 16 0.0223
29 RHEUMATOID FACTOR POSITIVE 113 0.0195
30 OBSTRUCTIVE SLEEP APNOEA SYNDROME 25 0.0171
31 VAGINAL DISCHARGE 171 0.0169
32 JOINT DISLOCATION 177 0.0167
33 BLOOD CALCIUM DECREASED 187 0.0166
34 HYPERCHOLESTEROLAEMIA 156 0.0161
35 PARAESTHESIA ORAL 232 0.0161
36 WOUND INFECTION 172 0.0157
37 WALKING AID USER 101 0.0153
38 RENAL FUNCTION TEST ABNORMAL 71 0.0153
39 MYOGLOBIN BLOOD INCREASED 23 0.0150
40 JOINT RANGE OF MOTION DECREASED 186 0.0139
41 ORAL CANDIDIASIS 177 0.0134
42 MUSCLE INJURY 110 0.0133
43 COLITIS MICROSCOPIC 62 0.0131
44 SPONDYLITIS 44 0.0121
45 LUPUS-LIKE SYNDROME 109 0.0120
46 EXOSTOSIS 107 0.0117
47 ORTHOSTATIC HYPOTENSION 200 0.0115
48 GRIP STRENGTH DECREASED 100 0.0114
49 PEMPHIGUS 140 0.0112
50 ORAL INTAKE REDUCED 27 0.0112
51 GLUCOSE TOLERANCE IMPAIRED 66 0.0111
52 POST HERPETIC NEURALGIA 16 0.0111
53 SPINAL FUSION SURGERY 45 0.0111
54 HELICOBACTER INFECTION 113 0.0110
55 IRRITABLE BOWEL SYNDROME 232 0.0108
56 PERICARDITIS 177 0.0105
57 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 68 0.0105
58 DUODENAL ULCER PERFORATION 77 0.0103
59 SCIATICA 165 0.0103
60 INJECTION RELATED REACTION 17 0.0103
61 OSTEOSCLEROSIS 16 0.0102
62 SYNOVITIS 178 0.0099
63 BREAST CANCER STAGE III 63 0.0097
64 RED BLOOD CELL SEDIMENTATION RATE INCREASED 106 0.0096
65 EXPOSURE TO TOXIC AGENT 30 0.0094
66 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 65 0.0091
67 PRESCRIBED UNDERDOSE 180 0.0090
68 FREQUENT BOWEL MOVEMENTS 239 0.0088
69 BRAIN NATRIURETIC PEPTIDE INCREASED 27 0.0087
70 FOLLICULITIS 90 0.0086
71 THERAPEUTIC REACTION TIME DECREASED 25 0.0086
72 AUTOIMMUNE DISORDER 82 0.0084
73 JOINT STIFFNESS 213 0.0081
74 PROCEDURAL PAIN 218 0.0079
75 ALCOHOL ABUSE 21 0.0078
76 OSTEOLYSIS 16 0.0078
77 HIP ARTHROPLASTY 119 0.0078
78 FOOT DEFORMITY 85 0.0077
79 IMMUNE THROMBOCYTOPENIA 35 0.0076
80 SLEEP DEFICIT 16 0.0076
81 HYPERLIPIDAEMIA 90 0.0075
82 RADIATION PNEUMONITIS 16 0.0075
83 PLANTAR FASCIITIS 25 0.0074
84 WOUND 205 0.0073
85 VOLVULUS 17 0.0072
86 PULMONARY FIBROSIS 137 0.0071
87 DRUG TOLERANCE DECREASED 20 0.0071
88 HAND DEFORMITY 92 0.0070
89 PURPURA 62 0.0070
90 AORTIC ARTERIOSCLEROSIS 18 0.0070
91 FIBROMYALGIA 170 0.0070
92 PRESCRIBED OVERDOSE 132 0.0068
93 INCREASED UPPER AIRWAY SECRETION 35 0.0068
94 SKIN ATROPHY 39 0.0068
95 PUSTULE 16 0.0067
96 TYPE 2 DIABETES MELLITUS 226 0.0067
97 SEDATION 175 0.0067
98 POOR QUALITY SLEEP 142 0.0066
99 OSTEOARTHRITIS 272 0.0064
100 INFUSION RELATED REACTION 422 0.0064
101 INFUSION SITE REACTION 19 0.0064
102 IMPAIRED QUALITY OF LIFE 91 0.0063
103 LIVER FUNCTION TEST INCREASED 134 0.0062
104 BONE LESION 22 0.0061
105 LOWER LIMB FRACTURE 114 0.0059
106 IMPAIRED HEALING 194 0.0059
107 COLITIS 220 0.0058
108 MOBILITY DECREASED 414 0.0058
109 GLOSSODYNIA 127 0.0057
110 KNEE ARTHROPLASTY 119 0.0056
111 DEPRESSED LEVEL OF CONSCIOUSNESS 223 0.0056
112 PERIPHERAL VENOUS DISEASE 23 0.0056
113 RECTAL HAEMORRHAGE 241 0.0056
114 HEPATIC CYST 19 0.0056
115 IMPAIRED WORK ABILITY 119 0.0056
116 FACET JOINT SYNDROME 18 0.0055
117 C-REACTIVE PROTEIN INCREASED 199 0.0055
118 LIVER INJURY 134 0.0055
119 COGNITIVE DISORDER 254 0.0054
120 OBSTRUCTIVE AIRWAYS DISORDER 60 0.0054
121 RHINITIS ALLERGIC 24 0.0054
122 INCORRECT DOSAGE ADMINISTERED 26 0.0053
123 LOOSE TOOTH 17 0.0053
124 UPPER RESPIRATORY TRACT INFECTION 242 0.0052
125 SPINAL OSTEOARTHRITIS 46 0.0052
126 HEPATIC CIRRHOSIS 98 0.0052
127 GAIT INABILITY 168 0.0050
128 GLAUCOMA 96 0.0050
129 OSTEOPOROSIS 203 0.0049
130 COLITIS ULCERATIVE 220 0.0049
131 SKIN REACTION 69 0.0049
132 HYPERAESTHESIA 40 0.0049
133 OESOPHAGITIS 52 0.0048
134 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 337 0.0047
135 HYPERKERATOSIS 25 0.0045
136 HAEMATOCHEZIA 248 0.0045
137 PARANASAL SINUS DISCOMFORT 17 0.0045
138 PSORIATIC ARTHROPATHY 182 0.0045
139 DYSPEPSIA 440 0.0045
140 METASTASES TO SPINE 15 0.0045
141 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
142 WHEEZING 263 0.0044
143 ENDOPHTHALMITIS 26 0.0043
144 OESOPHAGEAL PAIN 17 0.0043
145 DISABILITY 85 0.0043
146 ONYCHOMADESIS 18 0.0043
147 UMBILICAL HERNIA 20 0.0043
148 QUALITY OF LIFE DECREASED 57 0.0042
149 ABDOMINAL TENDERNESS 21 0.0042
150 THERMAL BURN 30 0.0042
151 PURULENT DISCHARGE 18 0.0042
152 ROAD TRAFFIC ACCIDENT 175 0.0042
153 PATHOLOGICAL FRACTURE 21 0.0041
154 PNEUMONIA ASPIRATION 103 0.0041
155 HYPOVOLAEMIA 24 0.0041
156 ORAL HERPES 80 0.0041
157 DIVERTICULUM 29 0.0041
158 OEDEMA 220 0.0041
159 SELF-INJURIOUS IDEATION 17 0.0040
160 BLADDER DISORDER 40 0.0040
161 CEREBRAL ATROPHY 16 0.0040
162 BALANCE DISORDER 346 0.0040
163 CANDIDIASIS 16 0.0040
164 INFUSION SITE SWELLING 25 0.0040
165 DELIRIUM 136 0.0039
166 INTERVERTEBRAL DISC DEGENERATION 36 0.0039
167 PROCTALGIA 25 0.0039
168 SYSTEMIC LUPUS ERYTHEMATOSUS 138 0.0039
169 NAIL DISORDER 34 0.0039
170 PERIPHERAL VASCULAR DISORDER 20 0.0039
171 CONSTIPATION 841 0.0039
172 DEFAECATION URGENCY 27 0.0038
173 GINGIVAL SWELLING 17 0.0038
174 LIP DRY 34 0.0037
175 SKIN PAPILLOMA 15 0.0037
176 PSEUDOMONAS INFECTION 32 0.0037
177 DIVERTICULITIS 102 0.0037
178 SENSATION OF FOREIGN BODY 31 0.0037
179 VENTRICULAR SEPTAL DEFECT 21 0.0037
180 URINE OUTPUT DECREASED 32 0.0037
181 PNEUMOTHORAX 58 0.0037
182 BLOOD ALBUMIN DECREASED 29 0.0037
183 STAPHYLOCOCCAL SEPSIS 18 0.0036
184 EAR INFECTION 97 0.0036
185 HIATUS HERNIA 47 0.0036
186 CONTUSION 349 0.0036
187 LUNG INFILTRATION 32 0.0036
188 ATELECTASIS 35 0.0036
189 CORONARY ARTERY STENOSIS 18 0.0036
190 FAECES SOFT 26 0.0036
191 ANORECTAL DISCOMFORT 19 0.0036
192 THYROID DISORDER 55 0.0036
193 DECREASED INTEREST 21 0.0036
194 ABNORMAL FAECES 29 0.0035
195 UVEITIS 48 0.0035
196 RENAL CYST 28 0.0035
197 NEUTROPHIL COUNT INCREASED 36 0.0035
198 SOMNAMBULISM 23 0.0035
199 RESPIRATORY RATE INCREASED 31 0.0035
200 DRUG-INDUCED LIVER INJURY 109 0.0035
201 ARTERIOSCLEROSIS CORONARY ARTERY 23 0.0035
202 BURSITIS 42 0.0035
203 APPLICATION SITE BURN 17 0.0034
204 C-REACTIVE PROTEIN ABNORMAL 22 0.0034
205 ONYCHOMYCOSIS 15 0.0034
206 GASTROINTESTINAL PAIN 37 0.0034
207 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 57 0.0034
208 SECRETION DISCHARGE 42 0.0034
209 GINGIVITIS 18 0.0033
210 BLEPHAROSPASM 21 0.0033
211 SKIN DISORDER 111 0.0033
212 HYPOMAGNESAEMIA 46 0.0033
213 SENSORY DISTURBANCE 53 0.0033
214 CELLULITIS 166 0.0033
215 INJECTION SITE PAPULE 15 0.0033
216 FAILURE TO THRIVE 17 0.0033
217 HYPOALBUMINAEMIA 25 0.0032
218 INFUSION SITE ERYTHEMA 27 0.0032
219 SINUSITIS 328 0.0032
220 DRUG ABUSE 266 0.0032
221 FOOD POISONING 17 0.0032
222 DERMATITIS CONTACT 36 0.0032
223 SQUAMOUS CELL CARCINOMA OF SKIN 19 0.0031
224 BLOOD CHOLESTEROL INCREASED 146 0.0031
225 SCRATCH 33 0.0031
226 SKIN INFECTION 35 0.0031
227 MIOSIS 25 0.0031
228 RASH VESICULAR 15 0.0031
229 MUSCULOSKELETAL CHEST PAIN 48 0.0031
230 EYE INFECTION 35 0.0031
231 BLISTER 174 0.0031
232 INJURY 217 0.0031
233 EAR PAIN 60 0.0031
234 HYDRONEPHROSIS 23 0.0031
235 WEIGHT DECREASED 856 0.0031
236 ONYCHOCLASIS 21 0.0030
237 STOMATITIS 185 0.0030
238 MUSCULAR WEAKNESS 346 0.0030
239 DYSURIA 112 0.0030
240 CATARACT 181 0.0030
241 HAEMORRHOIDS 59 0.0030
242 BONE DISORDER 55 0.0030
243 BRAIN OEDEMA 38 0.0030
244 HEPATIC ENZYME INCREASED 205 0.0030
245 SINUS BRADYCARDIA 29 0.0030
246 BODY HEIGHT DECREASED 32 0.0030
247 BRONCHITIS 219 0.0030
248 SPINAL DISORDER 28 0.0030
249 HYPOAESTHESIA 442 0.0030
250 AMNESIA 192 0.0029
251 METASTASES TO CENTRAL NERVOUS SYSTEM 38 0.0029
252 MOUTH SWELLING 17 0.0029
253 TOOTH ABSCESS 30 0.0029
254 MUSCULOSKELETAL STIFFNESS 258 0.0029
255 LYMPHOCYTE COUNT DECREASED 52 0.0029
256 FAECALOMA 16 0.0029
257 RASH MACULAR 102 0.0029
258 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 140 0.0029
259 TACHYCARDIA 258 0.0029
260 LYMPHOEDEMA 20 0.0029
261 LARGE INTESTINE POLYP 20 0.0029
262 BRONCHOSPASM 41 0.0029
263 INFUSION SITE PAIN 37 0.0029
264 ARTERIOSCLEROSIS 27 0.0029
265 OBSESSIVE-COMPULSIVE DISORDER 23 0.0029
266 METASTASES TO BONE 47 0.0029
267 MASS 40 0.0029
268 TENDONITIS 44 0.0028
269 EJECTION FRACTION DECREASED 44 0.0028
270 DECUBITUS ULCER 23 0.0028
271 ANAL FISTULA 15 0.0028
272 NEUROLOGICAL SYMPTOM 16 0.0028
273 GINGIVAL PAIN 22 0.0028
274 OSTEOMYELITIS 50 0.0028
275 TENDON DISORDER 18 0.0028
276 HYDROCEPHALUS 15 0.0028
277 HYPOKALAEMIA 127 0.0027
278 LOWER RESPIRATORY TRACT INFECTION 125 0.0027
279 OEDEMA PERIPHERAL 334 0.0027
280 ASTHENOPIA 15 0.0027
281 PRE-EXISTING CONDITION IMPROVED 17 0.0027
282 TOXICITY TO VARIOUS AGENTS 459 0.0027
283 ANOREXIA 35 0.0027
284 MICTURITION URGENCY 31 0.0027
285 DENTAL CARIES 30 0.0027
286 PRODUCTIVE COUGH 129 0.0027
287 TENDERNESS 28 0.0027
288 ODYNOPHAGIA 16 0.0027
289 SLEEP APNOEA SYNDROME 51 0.0027
290 BRONCHIECTASIS 18 0.0027
291 PULMONARY CONGESTION 35 0.0027
292 ABDOMINAL PAIN 616 0.0026
293 TRICUSPID VALVE INCOMPETENCE 21 0.0026
294 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
295 PERONEAL NERVE PALSY 15 0.0026
296 SPUTUM DISCOLOURED 25 0.0026
297 BLOOD IRON DECREASED 31 0.0026
298 REFUSAL OF TREATMENT BY PATIENT 17 0.0026
299 PRODUCT DISTRIBUTION ISSUE 24 0.0026
300 BURNING SENSATION 181 0.0026
301 PRODUCT FORMULATION ISSUE 17 0.0026
302 VITAMIN D DECREASED 22 0.0026
303 OSTEOPENIA 39 0.0026
304 MYOSITIS 23 0.0026
305 FEELING OF BODY TEMPERATURE CHANGE 15 0.0026
306 DISCOMFORT 156 0.0026
307 INCONTINENCE 27 0.0026
308 BLOOD MAGNESIUM DECREASED 22 0.0025
309 SCAB 29 0.0025
310 TOOTH FRACTURE 28 0.0025
311 BODY TEMPERATURE DECREASED 25 0.0025
312 POST-TRAUMATIC STRESS DISORDER 17 0.0025
313 HYPERTENSION 537 0.0025
314 SLEEP DISORDER 178 0.0025
315 TENDON PAIN 19 0.0025
316 PROTHROMBIN TIME PROLONGED 15 0.0025
317 GROIN PAIN 22 0.0025
318 INTRAOCULAR PRESSURE INCREASED 32 0.0025
319 RESTLESS LEGS SYNDROME 45 0.0025
320 OSTEONECROSIS OF JAW 61 0.0025
321 HERPES SIMPLEX 16 0.0025
322 ORAL DISORDER 18 0.0025
323 NEUROPATHY PERIPHERAL 233 0.0024
324 GASTROOESOPHAGEAL REFLUX DISEASE 197 0.0024
325 THERAPY NON-RESPONDER 110 0.0024
326 ANAL INCONTINENCE 22 0.0024
327 VISUAL IMPAIRMENT 303 0.0024
328 PARALYSIS 35 0.0024
329 CONFUSIONAL STATE 394 0.0024
330 GASTROENTERITIS VIRAL 44 0.0024
331 ACUTE RESPIRATORY DISTRESS SYNDROME 43 0.0024
332 SKIN HAEMORRHAGE 36 0.0024
333 ARTHRITIS 191 0.0024
334 GENERALISED OEDEMA 30 0.0024
335 SCOLIOSIS 15 0.0024
336 HAEMATOCRIT DECREASED 48 0.0024
337 NECK PAIN 135 0.0024
338 BLOOD PRESSURE SYSTOLIC INCREASED 47 0.0024
339 LOCAL SWELLING 42 0.0024
340 WITHDRAWAL SYNDROME 101 0.0024
341 PERIPHERAL SWELLING 370 0.0024
342 NASAL DISCOMFORT 19 0.0024
343 BONE DENSITY DECREASED 75 0.0024
344 ARTHROPATHY 133 0.0024
345 ANAEMIA 456 0.0024
346 BLOOD UREA INCREASED 40 0.0024
347 PAROSMIA 18 0.0024
348 UROSEPSIS 22 0.0024
349 CONTRAINDICATED PRODUCT ADMINISTERED 72 0.0024
350 EYE PAIN 134 0.0024
351 PHOTOPSIA 15 0.0024
352 DIZZINESS POSTURAL 23 0.0024
353 ULCER HAEMORRHAGE 16 0.0024
354 DYSSTASIA 69 0.0024
355 PYREXIA 817 0.0024
356 PRODUCT LABEL ISSUE 16 0.0024
357 PULMONARY MASS 35 0.0023
358 WEIGHT INCREASED 526 0.0023
359 MUSCULOSKELETAL PAIN 123 0.0023
360 GAIT DISTURBANCE 449 0.0023
361 PHOTOPHOBIA 44 0.0023
362 ECCHYMOSIS 16 0.0023
363 METASTASES TO LIVER 41 0.0023
364 INFECTION 337 0.0023
365 ORAL PAIN 52 0.0023
366 SKIN ULCER 60 0.0023
367 JOINT EFFUSION 16 0.0023
368 NASOPHARYNGITIS 425 0.0023
369 MOVEMENT DISORDER 74 0.0023
370 NIGHT SWEATS 74 0.0023
371 SINUS CONGESTION 31 0.0023
372 CIRCULATORY COLLAPSE 39 0.0023
373 ASPIRATION 25 0.0023
374 BLOOD CALCIUM INCREASED 20 0.0023
375 SCAR 39 0.0023
376 IRON DEFICIENCY ANAEMIA 21 0.0023
377 SMALL INTESTINAL OBSTRUCTION 28 0.0023
378 LIVE BIRTH 19 0.0023
379 PAPULE 16 0.0023
380 GINGIVAL BLEEDING 31 0.0023
381 APPLICATION SITE PAIN 50 0.0023
382 HYPOPHAGIA 58 0.0023
383 DEHYDRATION 302 0.0023
384 SEASONAL ALLERGY 32 0.0023
385 VITAMIN D DEFICIENCY 22 0.0023
386 PANIC ATTACK 82 0.0022
387 HYPOXIA 79 0.0022
388 SKIN DISCOLOURATION 103 0.0022
389 NEUTROPENIC SEPSIS 16 0.0022
390 VITREOUS FLOATERS 22 0.0022
391 PAIN IN EXTREMITY 659 0.0022
392 MALNUTRITION 25 0.0022
393 MENTAL STATUS CHANGES 62 0.0022
394 SQUAMOUS CELL CARCINOMA 21 0.0022
395 MEMORY IMPAIRMENT 306 0.0022
396 MUSCLE DISORDER 18 0.0022
397 MUSCLE TIGHTNESS 36 0.0022
398 NEURALGIA 54 0.0022
399 COAGULOPATHY 37 0.0022
400 ERYTHEMA 456 0.0022
401 URTICARIA 371 0.0022
402 FAECES DISCOLOURED 48 0.0022
403 IMMUNODEFICIENCY 33 0.0022
404 TOOTHACHE 40 0.0022
405 MUSCULOSKELETAL DISCOMFORT 38 0.0022
406 PAIN 1355 0.0022
407 DRUG TOXICITY 30 0.0022
408 TOOTH INFECTION 29 0.0022
409 IMPAIRED DRIVING ABILITY 25 0.0022
410 UPPER GASTROINTESTINAL HAEMORRHAGE 37 0.0022
411 PSORIASIS 287 0.0022
412 RASH PUSTULAR 16 0.0022
413 JOINT SWELLING 265 0.0022
414 HERPES ZOSTER 126 0.0022
415 APHTHOUS ULCER 17 0.0022
416 HYPOAESTHESIA ORAL 33 0.0022
417 HYPERCALCAEMIA 27 0.0022
418 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
419 GASTRITIS 57 0.0022
420 LOWER GASTROINTESTINAL HAEMORRHAGE 16 0.0022
421 ELECTROLYTE IMBALANCE 25 0.0021
422 INTERVERTEBRAL DISC PROTRUSION 47 0.0021
423 DYSPHAGIA 204 0.0021
424 POISONING 27 0.0021
425 CHEST PAIN 398 0.0021
426 HYPERSENSITIVITY 397 0.0021
427 LIMB DISCOMFORT 66 0.0021
428 CANDIDA INFECTION 36 0.0021
429 BEDRIDDEN 28 0.0021
430 PARAESTHESIA 335 0.0021
431 FACIAL PAIN 19 0.0021
432 IMPAIRED GASTRIC EMPTYING 29 0.0021
433 MIGRAINE 203 0.0021
434 DYSPNOEA EXERTIONAL 80 0.0021
435 LIGAMENT SPRAIN 21 0.0021
436 BLOOD SODIUM DECREASED 40 0.0021
437 PNEUMONIA 686 0.0021
438 SKIN LACERATION 23 0.0021
439 NEPHROLITHIASIS 97 0.0021
440 CARDIOMEGALY 26 0.0021
441 TOOTH DISORDER 47 0.0021
442 ABDOMINAL DISCOMFORT 354 0.0021
443 POLLAKIURIA 88 0.0021
444 INSOMNIA 561 0.0021
445 BRAIN FOG 33 0.0021
446 SWELLING 197 0.0021
447 DRUG INTOLERANCE 203 0.0021
448 FALL 699 0.0021
449 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36 0.0021
450 FLATULENCE 119 0.0021
451 PHARYNGITIS 26 0.0021
452 ASTHMA 236 0.0021
453 AGEUSIA 52 0.0021
454 EMPHYSEMA 21 0.0021
455 HAEMOPTYSIS 58 0.0021
456 SKIN LESION 57 0.0021
457 METASTASES TO LUNG 24 0.0021
458 POLYURIA 17 0.0021
459 DEMENTIA 58 0.0021
460 CARPAL TUNNEL SYNDROME 29 0.0021
461 CONCUSSION 16 0.0021
462 UPPER-AIRWAY COUGH SYNDROME 17 0.0021
463 MENTAL IMPAIRMENT 50 0.0021
464 NOCTURIA 25 0.0021
465 ANHEDONIA 54 0.0021
466 EOSINOPHILIA 36 0.0021
467 INFLAMMATION 106 0.0021
468 DYSPHONIA 120 0.0020
469 LETHARGY 118 0.0020
470 IMMUNE SYSTEM DISORDER 27 0.0020
471 SPINAL PAIN 24 0.0020
472 PAIN IN JAW 58 0.0020
473 INITIAL INSOMNIA 21 0.0020
474 ECONOMIC PROBLEM 31 0.0020
475 JAUNDICE 55 0.0020
476 NASAL CONGESTION 120 0.0020
477 BACK PAIN 473 0.0020
478 THERAPY CHANGE 20 0.0020
479 MITRAL VALVE INCOMPETENCE 23 0.0020
480 FLANK PAIN 19 0.0020
481 ERECTILE DYSFUNCTION 52 0.0020
482 VOMITING 952 0.0020
483 ARTHROPOD BITE 15 0.0020
484 LACRIMATION INCREASED 61 0.0020
485 HYPOTENSION 405 0.0020
486 HYPOCALCAEMIA 38 0.0020
487 GOUT 36 0.0020
488 HYPOTHYROIDISM 64 0.0020
489 ANXIETY 569 0.0020
490 URINARY INCONTINENCE 59 0.0020
491 INTESTINAL OBSTRUCTION 75 0.0020
492 DECREASED APPETITE 462 0.0020
493 LOCALISED INFECTION 48 0.0020
494 MIDDLE INSOMNIA 37 0.0020
495 MUSCLE SPASMS 362 0.0020
496 CLOSTRIDIUM DIFFICILE INFECTION 43 0.0020
497 SINUS DISORDER 39 0.0020
498 DRY THROAT 20 0.0020
499 PRODUCT SUBSTITUTION ISSUE 113 0.0020
500 DRUG EFFECT LESS THAN EXPECTED 29 0.0020
501 RENAL FAILURE CHRONIC 15 0.0019
502 NERVE COMPRESSION 18 0.0019
503 STATUS EPILEPTICUS 22 0.0019
504 NIGHTMARE 67 0.0019
505 LEUKOCYTOSIS 35 0.0019
506 THINKING ABNORMAL 36 0.0019
507 PAIN OF SKIN 52 0.0019
508 TOOTH EXTRACTION 24 0.0019
509 ACCIDENT 23 0.0019
510 VENTRICULAR EXTRASYSTOLES 20 0.0019
511 DRY MOUTH 156 0.0019
512 HYPONATRAEMIA 108 0.0019
513 ABDOMINAL DISTENSION 200 0.0019
514 NODULE 25 0.0019
515 MYALGIA 324 0.0019
516 OVARIAN CYST 19 0.0019
517 VISUAL ACUITY REDUCED 63 0.0019
518 TINNITUS 87 0.0019
519 HAEMATOMA 49 0.0019
520 OBESITY 30 0.0019
521 DIZZINESS 938 0.0019
522 ATRIAL FLUTTER 15 0.0019
523 HEART RATE DECREASED 66 0.0019
524 HEPATIC STEATOSIS 35 0.0019
525 NAUSEA 1483 0.0019
526 FEEDING DISORDER 38 0.0019
527 ROTATOR CUFF SYNDROME 24 0.0019
528 FISTULA 21 0.0019
529 MALAISE 819 0.0019
530 COORDINATION ABNORMAL 26 0.0019
531 BLOOD POTASSIUM DECREASED 56 0.0019
532 RHINITIS 15 0.0019
533 SYNCOPE 186 0.0019
534 BACTERAEMIA 22 0.0019
535 ILEUS 23 0.0018
536 INCREASED TENDENCY TO BRUISE 17 0.0018
537 CRYING 67 0.0018
538 PRURITUS 708 0.0018
539 PLEURAL EFFUSION 112 0.0018
540 BACK INJURY 20 0.0018
541 HYPERGLYCAEMIA 67 0.0018
542 RESPIRATORY SYNCYTIAL VIRUS INFECTION 16 0.0018
543 BREAST CANCER STAGE I 17 0.0018
544 MUCOSAL INFLAMMATION 48 0.0018
545 GENERAL PHYSICAL HEALTH DETERIORATION 212 0.0018
546 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
547 HYPERKALAEMIA 64 0.0018
548 SWOLLEN TONGUE 57 0.0018
549 DIARRHOEA 1175 0.0018
550 DIARRHOEA HAEMORRHAGIC 17 0.0018
551 ANKLE FRACTURE 28 0.0018
552 POST PROCEDURAL HAEMORRHAGE 21 0.0018
553 HEADACHE 1131 0.0018
554 ANGER 61 0.0018
555 URINARY TRACT INFECTION 307 0.0018
556 RIB FRACTURE 37 0.0018
557 PARANOIA 31 0.0018
558 FEELING HOT 110 0.0018
559 FEBRILE NEUTROPENIA 119 0.0018
560 APHONIA 25 0.0018
561 ATRIAL SEPTAL DEFECT 15 0.0018
562 THIRST 32 0.0018
563 CYSTITIS 57 0.0018
564 RASH PRURITIC 97 0.0018
565 STAPHYLOCOCCAL INFECTION 59 0.0018
566 PALPITATIONS 209 0.0018
567 ARTHRALGIA 742 0.0018
568 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
569 MUSCLE TWITCHING 41 0.0018
570 CHEST DISCOMFORT 182 0.0018
571 RASH GENERALISED 46 0.0018
572 VERTIGO 108 0.0018
573 DYSPNOEA 1003 0.0018
574 BACTERIAL INFECTION 33 0.0018
575 DEPRESSION 402 0.0018
576 RESPIRATORY TRACT INFECTION 46 0.0018
577 HALLUCINATION 133 0.0018
578 HERNIA 34 0.0018
579 FATIGUE 1368 0.0018
580 PHOTOSENSITIVITY REACTION 29 0.0018
581 HYPOGLYCAEMIA 85 0.0018
582 RED BLOOD CELL COUNT DECREASED 50 0.0017
583 INTENTIONAL PRODUCT USE ISSUE 153 0.0017
584 HAEMOGLOBIN DECREASED 179 0.0017
585 TREMOR 289 0.0017
586 POOR VENOUS ACCESS 18 0.0017
587 RESPIRATORY DISTRESS 48 0.0017
588 MUSCLE ATROPHY 22 0.0017
589 SWELLING FACE 113 0.0017
590 CARDIAC MURMUR 15 0.0017
591 BLOOD PRESSURE INCREASED 265 0.0017
592 JOINT INJURY 37 0.0017
593 VISION BLURRED 237 0.0017
594 CHILLS 202 0.0017
595 APHASIA 52 0.0017
596 APPLICATION SITE ERYTHEMA 45 0.0017
597 ASPARTATE AMINOTRANSFERASE INCREASED 91 0.0017
598 FUNGAL INFECTION 57 0.0017
599 BLOOD PRESSURE FLUCTUATION 41 0.0017
600 DRUG EXPOSURE DURING PREGNANCY 58 0.0017
601 LACERATION 16 0.0017
602 RESPIRATORY TRACT CONGESTION 27 0.0017
603 GASTROINTESTINAL DISORDER 152 0.0017
604 HAEMATEMESIS 43 0.0017
605 THERAPY CESSATION 87 0.0017
606 DIPLOPIA 44 0.0017
607 CYST 21 0.0017
608 SKIN FISSURES 33 0.0017
609 BREAST PAIN 18 0.0017
610 CORONARY ARTERY DISEASE 51 0.0017
611 GASTROINTESTINAL INFECTION 15 0.0017
612 ALOPECIA 327 0.0017
613 BLOOD POTASSIUM INCREASED 27 0.0017
614 ALANINE AMINOTRANSFERASE INCREASED 102 0.0017
615 ABASIA 41 0.0017
616 HALLUCINATION, VISUAL 35 0.0017
617 EAR DISCOMFORT 17 0.0017
618 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 86 0.0016
619 RHEUMATOID ARTHRITIS 187 0.0016
620 ASTHENIA 619 0.0016
621 PRESYNCOPE 40 0.0016
622 ATRIAL FIBRILLATION 160 0.0016
623 EYE DISORDER 54 0.0016
624 BLOOD TRIGLYCERIDES INCREASED 29 0.0016
625 TOOTH LOSS 34 0.0016
626 RHINORRHOEA 106 0.0016
627 CHROMATURIA 37 0.0016
628 BONE PAIN 96 0.0016
629 INJECTION SITE NODULE 18 0.0016
630 INSURANCE ISSUE 25 0.0016
631 BLOOD URINE PRESENT 31 0.0016
632 COUGH 457 0.0016
633 BLOOD BILIRUBIN INCREASED 44 0.0016
634 TASTE DISORDER 33 0.0016
635 LYMPHOPENIA 23 0.0016
636 WEIGHT FLUCTUATION 17 0.0016
637 GRAND MAL CONVULSION 15 0.0016
638 TENDON RUPTURE 20 0.0016
639 SINUS TACHYCARDIA 23 0.0016
640 LEUKOPENIA 81 0.0016
641 NEUTROPHIL COUNT DECREASED 66 0.0016
642 PNEUMONITIS 44 0.0016
643 RENAL PAIN 17 0.0016
644 ATAXIA 19 0.0016
645 ABDOMINAL PAIN UPPER 329 0.0016
646 RETCHING 34 0.0016
647 VIRAL INFECTION 53 0.0016
648 DERMATITIS ALLERGIC 20 0.0016
649 HYPERTHYROIDISM 23 0.0016
650 CHOLELITHIASIS 52 0.0016
651 DEEP VEIN THROMBOSIS 103 0.0016
652 HEAD INJURY 50 0.0016
653 RASH 688 0.0016
654 ACUTE KIDNEY INJURY 241 0.0016
655 PRURITUS GENERALISED 34 0.0016
656 LUNG DISORDER 77 0.0016
657 MYOCARDITIS 18 0.0016
658 BODY TEMPERATURE INCREASED 32 0.0016
659 DEAFNESS 41 0.0016
660 ACTIVITIES OF DAILY LIVING IMPAIRED 31 0.0016
661 BLOOD PRESSURE DECREASED 104 0.0016
662 EUPHORIC MOOD 16 0.0016
663 MYDRIASIS 20 0.0016
664 PLATELET COUNT DECREASED 166 0.0016
665 HOT FLUSH 117 0.0016
666 WHITE BLOOD CELL COUNT DECREASED 168 0.0015
667 TACHYPNOEA 21 0.0015
668 MENTAL DISORDER 67 0.0015
669 WHITE BLOOD CELL COUNT INCREASED 59 0.0015
670 BACK DISORDER 25 0.0015
671 HYPERSOMNIA 44 0.0015
672 INFLAMMATORY BOWEL DISEASE 15 0.0015
673 PHARYNGEAL SWELLING 15 0.0015
674 TREATMENT FAILURE 127 0.0015
675 RENAL FAILURE ACUTE 65 0.0015
676 PERIPHERAL COLDNESS 21 0.0015
677 NERVE INJURY 17 0.0015
678 RASH MACULO-PAPULAR 34 0.0015
679 DERMATITIS 32 0.0015
680 HEART RATE INCREASED 151 0.0015
681 DYSGEUSIA 113 0.0015
682 SOMNOLENCE 306 0.0015
683 RASH PAPULAR 34 0.0015
684 ORAL DISCOMFORT 21 0.0015
685 ULCER 24 0.0015
686 INTERNATIONAL NORMALISED RATIO INCREASED 43 0.0015
687 RASH ERYTHEMATOUS 72 0.0015
688 ABDOMINAL PAIN LOWER 38 0.0015
689 URINARY RETENTION 50 0.0015
690 SUICIDAL IDEATION 137 0.0015
691 THROAT IRRITATION 67 0.0015
692 GAMMA-GLUTAMYLTRANSFERASE INCREASED 33 0.0015
693 DISORIENTATION 59 0.0015
694 PANCYTOPENIA 83 0.0015
695 DISTURBANCE IN ATTENTION 80 0.0015
696 ADRENAL INSUFFICIENCY 18 0.0015
697 DECREASED ACTIVITY 16 0.0015
698 RENAL DISORDER 69 0.0015
699 OROPHARYNGEAL PAIN 137 0.0015
700 THERAPEUTIC PRODUCT EFFECT DECREASED 66 0.0015
701 GASTRIC ULCER 28 0.0015
702 FEELING COLD 41 0.0015
703 MOTOR DYSFUNCTION 15 0.0015
704 MUSCULOSKELETAL DISORDER 28 0.0015
705 CONDITION AGGRAVATED 447 0.0015
706 DRUG ERUPTION 26 0.0015
707 INJECTION SITE INDURATION 19 0.0015
708 DRY EYE 73 0.0015
709 EMOTIONAL DISORDER 45 0.0015
710 DRUG INTERACTION 230 0.0014
711 INFLUENZA LIKE ILLNESS 119 0.0014
712 AGITATION 106 0.0014
713 THROAT TIGHTNESS 39 0.0014
714 ABSCESS 23 0.0014
715 LIP SWELLING 48 0.0014
716 FEELING ABNORMAL 345 0.0014
717 BLOOD CREATININE INCREASED 94 0.0014
718 ECZEMA 75 0.0014
719 MYOCLONUS 17 0.0014
720 OXYGEN SATURATION DECREASED 80 0.0014
721 COLD SWEAT 25 0.0014
722 COMPLETED SUICIDE 118 0.0014
723 LYMPHADENOPATHY 50 0.0014
724 SPEECH DISORDER 74 0.0014
725 HEAD DISCOMFORT 25 0.0014
726 EATING DISORDER 30 0.0014
727 BLOOD PRESSURE ABNORMAL 28 0.0014
728 HYPERHIDROSIS 181 0.0014
729 ACUTE RESPIRATORY FAILURE 27 0.0014
730 DEPRESSED MOOD 74 0.0014
731 FLUSHING 142 0.0014
732 NO THERAPEUTIC RESPONSE 17 0.0014
733 PULMONARY HYPERTENSION 29 0.0014
734 LOSS OF CONSCIOUSNESS 178 0.0014
735 MYELODYSPLASTIC SYNDROME 20 0.0014
736 BIPOLAR DISORDER 15 0.0014
737 NERVOUSNESS 72 0.0014
738 PULMONARY THROMBOSIS 15 0.0014
739 LIVER FUNCTION TEST ABNORMAL 40 0.0014
740 APATHY 20 0.0014
741 END STAGE RENAL DISEASE 25 0.0014
742 GASTROENTERITIS 20 0.0014
743 SPLENOMEGALY 16 0.0014
744 INJECTION SITE WARMTH 28 0.0014
745 ANGINA PECTORIS 39 0.0014
746 SEPTIC SHOCK 59 0.0014
747 COVID-19 PNEUMONIA 16 0.0014
748 SEPSIS 151 0.0014
749 DISSEMINATED INTRAVASCULAR COAGULATION 19 0.0013
750 PULMONARY EMBOLISM 128 0.0013
751 BASAL CELL CARCINOMA 21 0.0013
752 HAIR TEXTURE ABNORMAL 18 0.0013
753 GALLBLADDER DISORDER 24 0.0013
754 COMA 64 0.0013
755 CHOLECYSTITIS 16 0.0013
756 RESPIRATORY ARREST 37 0.0013
757 PRODUCT USE COMPLAINT 21 0.0013
758 INFLUENZA 148 0.0013
759 ASCITES 39 0.0013
760 EPISTAXIS 99 0.0013
761 FOOT FRACTURE 25 0.0013
762 HAEMATURIA 45 0.0013
763 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
764 UPPER LIMB FRACTURE 26 0.0013
765 SKIN CANCER 28 0.0013
766 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 71 0.0013
767 DRUG INEFFECTIVE 1704 0.0013
768 ERUCTATION 25 0.0013
769 AGRANULOCYTOSIS 24 0.0013
770 ANAPHYLACTIC REACTION 71 0.0013
771 RESTLESSNESS 47 0.0013
772 OFF LABEL USE 1121 0.0013
773 SEXUAL DYSFUNCTION 15 0.0013
774 MULTI-ORGAN FAILURE 22 0.0013
775 RENAL FAILURE 168 0.0013
776 HALLUCINATION, AUDITORY 20 0.0013
777 SKIN EXFOLIATION 106 0.0013
778 MOOD SWINGS 40 0.0013
779 DYSKINESIA 51 0.0013
780 BLOOD COUNT ABNORMAL 19 0.0013
781 SNEEZING 28 0.0012
782 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
783 HIP FRACTURE 40 0.0012
784 LIVER DISORDER 55 0.0012
785 HEMIPARESIS 21 0.0012
786 HEART RATE IRREGULAR 28 0.0012
787 CHRONIC KIDNEY DISEASE 94 0.0012
788 HYPOACUSIS 53 0.0012
789 HEPATIC FAILURE 37 0.0012
790 FEAR 33 0.0012
791 RHABDOMYOLYSIS 51 0.0012
792 SEIZURE 141 0.0012
793 HUNGER 17 0.0012
794 CARDIOMYOPATHY 18 0.0012
795 EYE IRRITATION 70 0.0012
796 WRONG TECHNIQUE IN DRUG USAGE PROCESS 44 0.0012
797 EPILEPSY 37 0.0012
798 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
799 APPLICATION SITE IRRITATION 15 0.0012
800 GASTROINTESTINAL HAEMORRHAGE 100 0.0012
801 ABNORMAL DREAMS 33 0.0012
802 MALIGNANT MELANOMA 16 0.0012
803 RESPIRATORY FAILURE 87 0.0012
804 DRY SKIN 159 0.0012
805 SUBDURAL HAEMATOMA 17 0.0012
806 MOUTH ULCERATION 25 0.0012
807 CARDIAC DISORDER 111 0.0012
808 BLOOD CREATINE PHOSPHOKINASE INCREASED 34 0.0012
809 HEPATITIS 30 0.0012
810 BRADYCARDIA 62 0.0012
811 PRODUCT DOSE OMISSION IN ERROR 33 0.0012
812 APPLICATION SITE RASH 16 0.0012
813 UNRESPONSIVE TO STIMULI 30 0.0012
814 DIABETES MELLITUS 88 0.0012
815 THERAPY PARTIAL RESPONDER 18 0.0012
816 HEPATIC FUNCTION ABNORMAL 43 0.0012
817 PLATELET COUNT INCREASED 15 0.0011
818 CARDIO-RESPIRATORY ARREST 48 0.0011
819 APPLICATION SITE PRURITUS 26 0.0011
820 NEUROTOXICITY 20 0.0011
821 ENCEPHALOPATHY 28 0.0011
822 HAEMORRHAGE INTRACRANIAL 17 0.0011
823 THERAPEUTIC RESPONSE UNEXPECTED 51 0.0011
824 ILLNESS 117 0.0011
825 ADVERSE REACTION 15 0.0011
826 IRRITABILITY 68 0.0011
827 FEMUR FRACTURE 35 0.0011
828 CHOKING 22 0.0011
829 EYE HAEMORRHAGE 15 0.0011
830 NERVOUS SYSTEM DISORDER 35 0.0011
831 LABORATORY TEST ABNORMAL 33 0.0011
832 ADVERSE DRUG REACTION 100 0.0011
833 PHARYNGEAL OEDEMA 17 0.0011
834 DEVICE RELATED INFECTION 17 0.0011
835 HYPOKINESIA 16 0.0011
836 PLASMA CELL MYELOMA 43 0.0011
837 INJECTION SITE URTICARIA 27 0.0011
838 THROMBOCYTOPENIA 123 0.0011
839 ACUTE HEPATIC FAILURE 15 0.0011
840 LUNG INFECTION 17 0.0011
841 CEREBRAL HAEMORRHAGE 39 0.0011
842 ABNORMAL BEHAVIOUR 43 0.0011
843 INTENTIONAL PRODUCT MISUSE 95 0.0011
844 AGGRESSION 54 0.0011
845 COLON CANCER 16 0.0011
846 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 25 0.0011
847 KIDNEY INFECTION 21 0.0011
848 LIMB INJURY 29 0.0011
849 INJECTION SITE BRUISING 85 0.0011
850 DYSARTHRIA 40 0.0011
851 FLUID RETENTION 54 0.0011
852 PULMONARY OEDEMA 47 0.0010
853 CONVULSION 60 0.0010
854 NEOPLASM MALIGNANT 70 0.0010
855 EYE SWELLING 39 0.0010
856 MULTIPLE SCLEROSIS 50 0.0010
857 INJECTION SITE PRURITUS 70 0.0010
858 ACNE 79 0.0010
859 PERICARDIAL EFFUSION 24 0.0010
860 PRODUCT USE ISSUE 195 0.0010
861 ANOSMIA 15 0.0010
862 RESPIRATORY DISORDER 31 0.0010
863 OSTEONECROSIS 34 0.0010
864 STEVENS-JOHNSON SYNDROME 23 0.0010
865 THROMBOSIS 83 0.0010
866 PANCREATITIS ACUTE 23 0.0010
867 COVID-19 178 0.0010
868 DISEASE PROGRESSION 120 0.0010
869 INJECTION SITE PAIN 307 0.0010
870 METABOLIC ACIDOSIS 32 0.0010
871 INJECTION SITE MASS 37 0.0010
872 SPINAL FRACTURE 20 0.0010
873 FEELING JITTERY 19 0.0010
874 PALLOR 27 0.0010
875 POST PROCEDURAL COMPLICATION 19 0.0010
876 NEUTROPENIA 134 0.0010
877 CEREBRAL INFARCTION 24 0.0010
878 TRANSIENT ISCHAEMIC ATTACK 33 0.0010
879 UNEVALUABLE EVENT 74 0.0010
880 MALIGNANT NEOPLASM PROGRESSION 100 0.0010
881 RENAL IMPAIRMENT 82 0.0010
882 BLOOD GLUCOSE ABNORMAL 18 0.0010
883 ELECTROCARDIOGRAM QT PROLONGED 35 0.0010
884 DRUG LEVEL INCREASED 16 0.0010
885 ADVERSE EVENT 89 0.0010
886 GASTRIC DISORDER 33 0.0010
887 ARRHYTHMIA 45 0.0009
888 INTENTIONAL DOSE OMISSION 27 0.0009
889 CARDIAC ARREST 78 0.0009
890 OVERDOSE 203 0.0009
891 PELVIC PAIN 17 0.0009
892 PRODUCT USE IN UNAPPROVED INDICATION 230 0.0009
893 EXTRAPYRAMIDAL DISORDER 23 0.0009
894 SURGERY 54 0.0009
895 CONJUNCTIVITIS 17 0.0009
896 ACUTE MYOCARDIAL INFARCTION 27 0.0009
897 MATERNAL EXPOSURE DURING PREGNANCY 81 0.0009
898 INTENTIONAL DRUG MISUSE 19 0.0009
899 SKIN BURNING SENSATION 65 0.0009
900 PREGNANCY 18 0.0009
901 CARDIAC FAILURE 72 0.0009
902 THERAPY INTERRUPTED 64 0.0009
903 PROTEINURIA 17 0.0009
904 NEOPLASM PROGRESSION 31 0.0009
905 CHOLESTASIS 17 0.0009
906 OCULAR HYPERAEMIA 42 0.0009
907 MOOD ALTERED 24 0.0009
908 DIABETIC KETOACIDOSIS 21 0.0009
909 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 157 0.0009
910 INJECTION SITE ERYTHEMA 108 0.0009
911 PRODUCT COMPLAINT 22 0.0009
912 LACTIC ACIDOSIS 28 0.0009
913 CARDIAC FAILURE CONGESTIVE 69 0.0009
914 INJECTION SITE REACTION 59 0.0009
915 ILL-DEFINED DISORDER 52 0.0009
916 TARDIVE DYSKINESIA 24 0.0008
917 CEREBROVASCULAR ACCIDENT 144 0.0008
918 CYTOKINE RELEASE SYNDROME 17 0.0008
919 INTERSTITIAL LUNG DISEASE 41 0.0008
920 FULL BLOOD COUNT DECREASED 17 0.0008
921 BLINDNESS 34 0.0008
922 EMOTIONAL DISTRESS 101 0.0008
923 SKIN IRRITATION 38 0.0008
924 PRODUCT PRESCRIBING ISSUE 18 0.0008
925 THERAPEUTIC RESPONSE DECREASED 50 0.0008
926 INJECTION SITE SWELLING 63 0.0008
927 MULTIPLE SCLEROSIS RELAPSE 56 0.0008
928 INJECTION SITE HAEMORRHAGE 65 0.0008
929 TREATMENT NONCOMPLIANCE 44 0.0008
930 PRODUCT QUALITY ISSUE 109 0.0008
931 FRACTURE 15 0.0008
932 GLYCOSYLATED HAEMOGLOBIN INCREASED 20 0.0008
933 ANGIOEDEMA 35 0.0008
934 NEEDLE ISSUE 23 0.0008
935 BONE MARROW FAILURE 16 0.0008
936 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
937 PRODUCT DOSE OMISSION ISSUE 228 0.0008
938 HAEMORRHAGE 81 0.0008
939 EYE PRURITUS 26 0.0008
940 DRUG DOSE OMISSION 127 0.0008
941 UNDERDOSE 56 0.0008
942 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 54 0.0008
943 BLOOD GLUCOSE DECREASED 36 0.0007
944 INJECTION SITE RASH 23 0.0007
945 INCORRECT DRUG ADMINISTRATION DURATION 21 0.0007
946 SHOCK 17 0.0007
947 PRODUCT DOSE OMISSION 48 0.0007
948 PRODUCT DISPENSING ERROR 16 0.0007
949 PREMATURE BABY 22 0.0007
950 MELAENA 16 0.0007
951 MEDICATION ERROR 40 0.0007
952 DRUG EFFECT INCOMPLETE 26 0.0007
953 BLOOD GLUCOSE INCREASED 134 0.0007
954 MYOCARDIAL INFARCTION 124 0.0007
955 DRUG WITHDRAWAL SYNDROME 62 0.0007
956 PSYCHOTIC DISORDER 20 0.0007
957 SUICIDE ATTEMPT 41 0.0007
958 DEVICE MALFUNCTION 47 0.0007
959 DRUG EFFECT DECREASED 36 0.0007
960 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 17 0.0007
961 EXPOSURE DURING PREGNANCY 41 0.0007
962 PANCREATIC CARCINOMA 19 0.0007
963 RENAL INJURY 19 0.0006
964 LUNG NEOPLASM MALIGNANT 26 0.0006
965 ANAPHYLACTIC SHOCK 16 0.0006
966 HOSPITALISATION 94 0.0006
967 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 28 0.0006
968 DRUG ADMINISTRATION ERROR 18 0.0006
969 FOETAL EXPOSURE DURING PREGNANCY 47 0.0006
970 PANCREATITIS 30 0.0006
971 ACCIDENTAL OVERDOSE 20 0.0005
972 DISEASE RECURRENCE 26 0.0005
973 THERAPEUTIC RESPONSE SHORTENED 18 0.0005
974 DRUG DEPENDENCE 87 0.0005
975 INCORRECT DOSE ADMINISTERED 121 0.0005
976 DEVICE DISLOCATION 23 0.0005
977 INTENTIONAL OVERDOSE 33 0.0005
978 VAGINAL HAEMORRHAGE 22 0.0005
979 DEATH 421 0.0005
980 DERMATITIS ATOPIC 25 0.0005
981 BREAST CANCER 43 0.0005
982 ABORTION SPONTANEOUS 18 0.0004
983 PRODUCT ADHESION ISSUE 16 0.0004
984 MYELOSUPPRESSION 16 0.0004
985 DEVICE ISSUE 39 0.0004
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 78 0.0004
987 EXTRA DOSE ADMINISTERED 15 0.0004
988 DEVICE DIFFICULT TO USE 24 0.0004
989 ACCIDENTAL EXPOSURE TO PRODUCT 36 0.0003
990 PRODUCT STORAGE ERROR 30 0.0003
991 PROSTATE CANCER 23 0.0003
992 NO ADVERSE EVENT 43 0.0002